Report cover image

Ride Hailing Services Market

Published Jan 12, 2026
Length 115 Pages
SKU # GV20873153

Description

Ride Hailing Services Market Summary

The global ride hailing services market size was estimated at USD 47.61 billion in 2025 and is projected to reach USD 181.54 billion by 2033, growing at a CAGR of 18.6% from 2026 to 2033. The popularity of the market for ride sharing has increased over the past several years as companies work toward improving transportation by making it more efficient, convenient, economical, and comfortable.

The prospect of self-driving cars, which are expected to significantly lower the cost of ride-hailing services, has contributed to the growing popularity of mobility-as-a-service (MaaS). Furthermore, banks and lenders have lowered their interest rates to make it simpler and less expensive to finance the purchase of an automobile. Employing fleets of automated vehicles helps businesses to innovate their services by enhancing the comfort and safety of passengers.

The rising population has led to problems such as increased traffic congestion, a lack of suitable public transport options, and longer wait times for public transportation services. As a result, ride hailing services are attracting more travelers as they provide faster and on-demand services. Increased fuel prices, increased vehicle maintenance costs, and the adoption of strict emission norms make ride hailing less expensive than owning a vehicle. These factors are expected to drive market growth over the forecast period.

The user-friendly booking options and convenience offered by these services are other key factors contributing to their growing demand. Digitally enabled car-sharing and ride hailing efficiently manage transport demands as well as provide convenient and environmentally friendly rides. This is handled through a single smartphone application, which is anticipated to generate a lucrative opportunity for the market during the forecast period.

As the ride hailing services require a huge workforce of trained drivers, the industry is receiving support from the governments of developing countries, including China and India. An increasing number of companies introducing innovation in services for the maximum comfort of commuters is also expected to boost the market.

Global Ride Hailing Services Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ride hailing services market report based on offering, and region:
  • Offering Outlook (Revenue, USD Billion, 2021 - 2033)
  • E-hailing
  • Car Sharing
  • Car Rental
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia & New Zealand
  • Central & South America
  • Brazil
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

115 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Application Segment
1.2.2. Therapeutic Area
1.2.3. End Use
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising demand for cost-effective drug development
3.2.1.2. Increasing clinical trials in drug repurposing
3.2.1.3. Growing focus on precision medicine and targeted drug development
3.2.2. Market restraint analysis
3.2.2.1. Highly regulated industry
3.2.2.2. High computational costs and infrastructure requirements
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Case Study Insights
3.4. Artificial Intelligence in Drug Discovery Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
3.4.2.6. Social Landscape
Chapter 4. Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Artificial Intelligence in Drug Discovery Market Application Movement Analysis
4.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
4.4. Drug optimization and repurposing
4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Preclinical testing
4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.6. Others
4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Artificial Intelligence in Drug Discovery Market Therapeutic Area Movement Analysis
5.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
5.4. Oncology
5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. Neurodegenerative Diseases
5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.6. Cardiovascular Disease
5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.7. Metabolic Diseases
5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.8. Infectious Disease
5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.9. Others
5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Artificial Intelligence in Drug Discovery Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Artificial Intelligence in Drug Discovery Market End Use Movement Analysis
6.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Contract Research Organizations (CROs)
6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Academic and Research Institutes
6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.7. Other
6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2025
8.4. Company Profiles/Listing
8.4.1. Healx
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. BostonGene Corporation
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. BenevolentAI
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Innophore
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Delta4.ai
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. BioXcel Therapeutics Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. BullFrog AI Holdings, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Graphwise
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Owkin, Inc
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Insilico Medicine
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. IBM
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Exscientia
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. Google (DeepMind)
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
8.4.14. BioSymetrics, Inc.
8.4.14.1. Company overview
8.4.14.2. Financial performance
8.4.14.3. Product benchmarking
8.4.14.4. Strategic initiatives
8.4.15. BPGbio Inc. (Berg Health)
8.4.15.1. Company overview
8.4.15.2. Financial performance
8.4.15.3. Product benchmarking
8.4.15.4. Strategic initiatives
8.4.16. Atomwise Inc.
8.4.16.1. Company overview
8.4.16.2. Financial performance
8.4.16.3. Product benchmarking
8.4.16.4. Strategic initiatives
8.4.17. Recursion
8.4.17.1. Company overview
8.4.17.2. Financial performance
8.4.17.3. Product benchmarking
8.4.17.4. Strategic initiatives
8.4.18. Aitia
8.4.18.1. Company overview
8.4.18.2. Financial performance
8.4.18.3. Product benchmarking
8.4.18.4. Strategic initiatives
8.4.19. Insitro
8.4.19.1. Company overview
8.4.19.2. Financial performance
8.4.19.3. Product benchmarking
8.4.19.4. Strategic initiatives
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.